UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Gabelli Funds LLC

Gabelli Funds LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 39,055 shares of the healthcare conglomerate’s stock after acquiring an additional 5,060 shares during the period. Gabelli Funds LLC’s holdings in UnitedHealth Group were worth $19,756,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $25,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $30,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 0.6 %

Shares of UNH stock opened at $583.43 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $438.50 and a fifty-two week high of $630.73. The stock has a market capitalization of $533.67 billion, a P/E ratio of 37.64, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a 50 day moving average price of $514.87 and a 200 day moving average price of $542.12.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the firm posted $5.83 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. UnitedHealth Group’s payout ratio is 54.19%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Truist Financial upped their price objective on shares of UnitedHealth Group from $610.00 to $660.00 and gave the company a “buy” rating in a report on Friday, April 11th. Twenty-one investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average target price of $632.85.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.